Login / Signup

Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathy.

Ján RemšíkJessica A WilcoxN Esther BabadyTracy McMillenBehroze A VachhaNeil A HalpernVikram DhawanMarc K RosenblumChristine A Iacobuzio-DonahueEdward K AvilaBianca D SantomassoAdrienne A Boire
Published in: medRxiv : the preprint server for health sciences (2020)
SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction. Here we show that a particularly vulnerable population with neurologic manifestations of COVID-19 harbor an influx of inflammatory cytokines within the cerebrospinal fluid in the absence of viral neuro-invasion. The majority of these inflammatory mediators are driven by type 2 interferon and are known to induce neuronal injury in other disease models. Levels of matrix metalloproteinase-10 within the spinal fluid correlate with the degree of neurologic dysfunction. Furthermore, this neuroinflammatory process persists weeks following convalescence from the acute respiratory infection. These prolonged neurologic sequelae following a systemic cytokine release syndrome lead to long-term neurocognitive dysfunction with a wide range of phenotypes.
Keyphrases